The world’s largest self-screening study for atrial fibrillation with continuous ECG uses ECG247. The study will include 35,000 participants from Norway. The researchers behind the study present the background and method in an article recently published in one of the world’s best medical journals in the field of heart rhythm disorders.
Read the article here